Keith Wayne Ward, Chief Development Officer at REATA PHARMACEUTICALS INC (RETA), sold 57,000 shares at $36.62 ($2.1M) on 2018-06-05, disclosed to the SEC on 2018-06-07.
Open-market sale of $2.1M RETA by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.62 | 28,500 | $1.0M | 50.0% |
| 2 | $36.62 | 28,500 | $1.0M | 50.0% |
| Total | $36.62 avg | 57,000 | $2.1M | 100% |
| Filing → |
| RETA | SELL | 2019-01-03 | $448K | — | Filing → |
| RETA | SELL | 2018-11-08 | $636K | — | Filing → |
| RETA | SELL | 2018-11-01 | $283K | — | Filing → |